Latest KFF Health News Stories
¿Quisieras que te hicieran pruebas genéticas como parte de tu chequeo anual?
El debate se generó cuando un sistema de salud anunció que comenzaría a secuenciar el ADN de 1,000 pacientes, como parte de un proyecto de atención primaria.
Are You And Your Primary Care Doc Ready To Talk About Your DNA?
The Pennsylvania-based health chain Geisinger plans to offer DNA sequencing as part of regular patient care.
Indocumentada y con cáncer: entre la muerte y la deportación
¿Qué sucede cuando un inmigrante indocumentado tiene un diagnóstico potencialmente mortal? Depende mucho de en dónde viva.
Choosing Between Death And Deportation
What happens when an undocumented immigrant has a life-threatening diagnosis? Much depends on where the person lives. And even in states with generous care for a dire illness, a patient can face difficult life-and-death choices.
Best Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes, who reads everything on health care to compile our daily Morning Briefing, offers the best and most provocative stories for the weekend.
‘Rapid Autopsy’ Programs Seek Clues To Cancer Within Hours Of Death
More than a dozen centers nationwide now ask terminal patients to allow speedy study of the diseases that kill them.
Médicos aprenden a hablar con sus pacientes sobre el final de la vida
Una guía busca ayudar a los médicos a conversar con sus pacientes terminales sobre un tema crítico que no siempre se aborda de la mejor manera.
Doctors Learn How To Talk To Patients About Dying
Clinicians can be so focused on fixing problems and saving lives that they often avoid talking to patients about their prognosis.
¿Son necesarias las mamografías en tres dimensiones?
Cada vez más centros de imágenes ofrecen esta alternativa, en vez de la mamografía tradicional. Sin embargo, expertos sugieren no recomendarlas ampliamente todavía.
Inside The Global Race To Deliver A Vital Radioactive Isotope Used To Detect Cancer
Moly-99, as it’s called, is created in just six government-owned nuclear research reactors — none in North America — raising concerns about the reliability of the supply.
When You Need A Breast Screening, Should You Get A 3-D Mammogram?
The newer images are more expensive, but it’s not yet clear if they are more effective in catching cancers that will kill.
Doing More Harm Than Good? Epidemic of Screening Burdens Nation’s Older Patients
Patients are often aggressively screened for cancer, even if they won’t live long enough to benefit.
Study Gives Mixed Reviews On Laws To Equalize Cancer Patients’ Out-Of-Pocket Costs
Most states have laws that require that cancer patients who get their treatment orally rather than by infusion in a doctor’s office not pay more out-of-pocket. A new study finds that the impact of those laws is mixed.
California Cracks Down On Weed Killer As Lawsuits Abound
California has listed the active ingredient in Monsanto’s Roundup as a cancer-causing agent and will require warning labels on it starting next year. The company says that the listing is unjustified and that science is on its side.
El doloroso costado positivo del marketing médico
Una paciente con cáncer de seno terminal asegura que los comerciales solo promueven curas milagrosas y pacientes felices. La realidad es distinta, asegura.
The Painful Side Of Positive Health Care Marketing
Advertising for hospitals, unlike pharmaceutical companies, doesn’t have to be backed up by data or facts. Cheerful messages of hope can feel like a slap in the face to a dying patient.
Tanta atención que duele: terapias y cirugías innecesarias agregan dolor y enfermedad
Las pruebas excesivas de cáncer de tiroides, próstata, seno y piel lleva a muchas personas mayores a someterse a tratamientos que no prolongarán sus vidas, pero que pueden causar dolor y sufrimiento innecesarios.
So Much Care It Hurts: Unneeded Scans, Therapy, Surgery Only Add To Patients’ Ills
Overtreatment of breast cancer and other diseases is pervasive, burdening patients and the health care system with enormous costs and needless suffering.
Cascade of Costs Could Push New Gene Therapy Above $1 Million Per Patient
The costs of using a new class of cancer treatments include far more than the drug’s sticker price.
As Care Shifts From Hospital To Home, Guarding Against Infection Falls To Families
Despite a lack of medical training, relatives increasingly are assigned complex, risky medical tasks at home, such as maintaining catheters. If done incorrectly, blood clots, infections, even death can result.
